DocGo (NASDAQ:DCGO) Lowered to “Hold” Rating by Deutsche Bank Aktiengesellschaft

DocGo (NASDAQ:DCGO) was downgraded by equities researchers at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating in a report issued on Friday, MarketBeat Ratings reports. They currently have a $2.85 price objective on the stock, down from their previous price objective of $5.00. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential downside of 27.30% from the stock’s previous close.

Separately, Needham & Company LLC decreased their target price on shares of DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a report on Friday. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $5.06.

DocGo Trading Down 3.4 %

Shares of DCGO stock opened at $3.92 on Friday. DocGo has a twelve month low of $2.75 and a twelve month high of $5.68. The company’s 50-day moving average price is $4.62 and its 200-day moving average price is $4.02. The stock has a market cap of $400.04 million, a price-to-earnings ratio of 14.00, a PEG ratio of 14.16 and a beta of 1.00.

Insider Buying and Selling at DocGo

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the transaction, the general counsel now owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. This trade represents a 11.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Centiva Capital LP acquired a new stake in shares of DocGo in the third quarter valued at $43,000. Summit Investment Advisors Inc. grew its position in DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after acquiring an additional 2,968 shares in the last quarter. Prudential Financial Inc. purchased a new stake in DocGo during the fourth quarter worth about $55,000. Intech Investment Management LLC acquired a new stake in shares of DocGo during the third quarter worth about $62,000. Finally, Royce & Associates LP purchased a new position in shares of DocGo in the fourth quarter valued at approximately $64,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.